Madison, WI – According to filings with the U.S. Securities and Exchange Commission, Imbed Biosciences is raising $1,507,600.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Ankit Agarwal played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Imbed Biosciences

Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced therapies for the treatment of burns, chronic ulcers, gastro-intestinal defects, and soft-tissue repair. The company has a portfolio of products in development based on its patented MicroLyte Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections.

To learn more about Imbed Biosciences, visit http://imbedbio.com/

Contact:
Ankit Agarwal, President and Chief Executive Officer
608-237-1525
ankit@imbedbio.com
https://www.linkedin.com/in/ankit-agarwal-414a606/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved